Analysts Set Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) PT at $91.83
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, four have given a buy recommendation and two […]
22 Mar 01:40 · The Cerbat Gem